Citations

Citations to this article as recorded by  

• Capillary blood as a complementary matrix for doping control purposes. Application to the definition of the individual longitudinal profile of IGF-1
  Carlotta Stacchini, Francesco Botrè, Xavier de la Torre, Monica Mazzarino
  Journal of Pharmaceutical and Biomedical Analysis.2023; 227: 115274.     CrossRef

Citations

Citations to this article as recorded by  

• Evaluation of Adult Height in Patients with Non-Permanent Idiopathic GH Deficiency
  Agnese Murianni, Anna Lussu, Chiara Guzzetti, Anastasia Ibba, Letizia Casula, Mariacarolina Salerno, Marco Cappa, Sandro Loche
  Endocrines.2023; 4(1): 169.     CrossRef
• Diagnosis of GH Deficiency Without GH Stimulation Tests
  Anastasia Ibba, Sandro Loche
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency
  Yun Jeong Lee, Yunha Choi, Han-Wook Yoo, Young Ah Lee, Choong Ho Shin, Han Saem Choi, Ho-Seong Kim, Jae Hyun Kim, Jung Eun Moon, Cheol Woo Ko, Moon Bae Ahn, Byung-Kyu Suh, Jin-Ho Choi
  Endocrinology and Metabolism.2022; 37(2): 359.     CrossRef
• A Radiomics-Based Model with the Potential to Differentiate Growth Hormone Deficiency and Idiopathic Short Stature on Sella MRI
  Taeyoun Lee, Kyungchul Song, Beomseok Sohn, Jihwan Eom, Sung Soo Ahn, Ho-Seong Kim, Seung-Koo Lee
  Yonsei Medical Journal.2022; 63(9): 856.     CrossRef
• Phenotypic spectrum of patients with mutations in CHD7: clinical implications of endocrinological findings
  Ja Hye Kim, Yunha Choi, Soojin Hwang, Gu-Hwan Kim, Han-Wook Yoo, Jin-Ho Choi
  Endocrine Connections.2022;[Epub]     CrossRef
• Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
  Hyemi Kwon, Eun Roh, Chang Ho Ahn, Hee Kyung Kim, Cheol Ryong Ku, Kyong Yeun Jung, Ju Hee Lee, Eun Heui Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Jun Sung Moon, Jin Hwa Kim, Mi-kyung Kim
  Endocrinology and Metabolism.2022; 37(6): 839.     CrossRef
• Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
  Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, Mi Kyung Kim, Chang Ho Ahn, Kyung Ae Lee, Seung Hun Lee, You-Bin Lee, Kyeong Hye Park, Yun Mi Choi, Namki Hong, A Ram Hong, Sang-Wook Kang, Byung Kwan Park, Moon-Woo Seong, Myungshin Kim, Kyeong Cheon Jung, Chan
  Endocrinology and Metabolism.2021; 36(2): 322.     CrossRef
• Asian Conference on Tumor Ablation Guidelines for Adrenal Tumor Ablation
  Byung Kwan Park, Masashi Fujimori, Shu-Huei Shen, Uei Pua
  Endocrinology and Metabolism.2021; 36(3): 553.     CrossRef
• Asian Conference on Tumor Ablation guidelines for renal cell carcinoma
  Byung Kwan Park, Shu-Huei Shen, Masashi Fujimori, Yi Wang
  Investigative and Clinical Urology.2021; 62(4): 378.     CrossRef
• Diagnosis and Treatment of Adult Growth Hormone Deficiency
  Jung Hee Kim
  The Korean Journal of Medicine.2021; 96(5): 400.     CrossRef

The Korean Endocrine Society (KES) published clinical practice guidelines for the treatment of acromegaly in 2011. Since then, the number of acromegaly cases, publications on studies addressing medical treatment of acromegaly, and demands for improvements in insurance coverage have been dramatically increasing. In 2017, the KES Committee of Health Insurance decided to publish a position statement regarding the use of somatostatin analogues in acromegaly. Accordingly, consensus opinions for the position statement were collected after intensive review of the relevant literature and discussions among experts affiliated with the KES, and the Korean Neuroendocrine Study Group. This position statement includes the characteristics, indications, dose, interval (including extended dose interval in case of lanreotide autogel), switching and preoperative use of somatostatin analogues in medical treatment of acromegaly. The recommended approach is based on the expert opinions in case of insufficient clinical evidence, and where discrepancies among the expert opinions were found, the experts voted to determine the recommended approach.

Citations

Citations to this article as recorded by  

• Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association
  A Ram Hong, Ho-Cheol Kang
  Endocrinology and Metabolism.2023; 38(2): 175.     CrossRef
• Evaluation and Management of Bone Health in Patients with Thyroid Diseases: a Position Statement from the Korean Thyroid Association
  A Ram Hong, Hwa Young Ahn, Bu Kyung Kim, Seong Hee Ahn, So Young Park, Min-Hee Kim, Jeongmin Lee, Sun Wook Cho, Ho-Cheol Kang
  International Journal of Thyroidology.2022; 15(1): 1.     CrossRef
• Octreotide in the treatment of acromegaly – the possibilities of high-dose therapy
  I. A. Ilovayskaya
  Meditsinskiy sovet = Medical Council.2022; (10): 148.     CrossRef
• Approach of Acromegaly during Pregnancy
  Alexandru Dan Popescu, Mara Carsote, Ana Valea, Andreea Gabriela Nicola, Ionela Teodora Dascălu, Tiberiu Tircă, Jaqueline Abdul-Razzak, Mihaela Jana Țuculină
  Diagnostics.2022; 12(11): 2669.     CrossRef
• Left to themselves: Time to target chronic pain in childhood rare diseases
  Christine B. Sieberg, Alyssa Lebel, Erin Silliman, Scott Holmes, David Borsook, Igor Elman
  Neuroscience & Biobehavioral Reviews.2021; 126: 276.     CrossRef
• Severe respiratory failure in a patient with COVID-19 and acromegaly: rapid improvement after adding octreotide
  Jacob Luty, LesleAnn Hayward, Melanie Jackson, P Barton Duell
  BMJ Case Reports.2021; 14(8): e243900.     CrossRef
• Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
  Cheol Ryong Ku, Vladimir Melnikov, Zhaoyun Zhang, Eun Jig Lee
  Endocrinology and Metabolism.2020; 35(2): 206.     CrossRef
• Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
  Sang Ouk Chin, Cheol Ryong Ku, Byung Joon Kim, Sung-Woon Kim, Kyeong Hye Park, Kee Ho Song, Seungjoon Oh, Hyun Koo Yoon, Eun Jig Lee, Jung Min Lee, Jung Soo Lim, Jung Hee Kim, Kwang Joon Kim, Heung Yong Jin, Dae Jung Kim, Kyung Ae Lee, Seong-Su Moon, Dong
  The Korean Journal of Medicine.2019; 94(6): 485.     CrossRef

Citations

Citations to this article as recorded by  

• Quality of life and patient satisfaction with raloxifene/cholecalciferol combination therapy in postmenopausal women
  Dong-Yun Lee, Yoon-Sok Chung
  Scientific Reports.2022;[Epub]     CrossRef
• Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis
  So Young Park, Moo-Il Kang, Hyung Moo Park, Yumie Rhee, Seong Hwan Moon, Hyun Koo Yoon, Jung-Min Koh, Jae Suk Chang, In Joo Kim, Ye Yeon Won, Ye Soo Park, Hoon Choi, Chan Soo Shin, Taek Rim Yoon, Sung-Cheol Yun, Ho-Yeon Chung
  Archives of Osteoporosis.2020;[Epub]     CrossRef
• Efficacy and safety of vitamin D3 B.O.N intramuscular injection in Korean adults with vitamin D deficiency
  Han Seok Choi, Yoon-Sok Chung, Yong Jun Choi, Da Hea Seo, Sung-Kil Lim
  Osteoporosis and Sarcopenia.2016; 2(4): 228.     CrossRef
• Pharmacologic treatment of osteoporosis
  Yong-Ki Min
  Journal of the Korean Medical Association.2016; 59(11): 847.     CrossRef

A macroinvasive pituitary adenoma with plurihormonality usually causes acromegaly and hyperprolactinemia, and also accompanies with neurologic symptoms such as visual disturbances. However, its concurrent presentation with a rectal carcinoid tumor is rarely observed. This study reports the history, biochemical, colonoscopic and immunohistochemical results of a 48-year-old female with acromegaly and hyperprolactinemia. Despite the large size and invasive nature of the pituitary adenoma to adjacent anatomical structures, she did not complain of any neurologic symptoms such as visual disturbance or headache. Immunohistochemical staining of the surgical specimen from the pituitary adenoma revealed that the tumor cells were positive for growth hormone (GH), prolactin (PRL), and thyroid stimulating hormone (TSH). Staining for pituitary-specific transcription factor-1 (Pit-1) was shown to be strongly positive, which could have been possibly contributing to the plurihormonality of this adenoma. Colonoscopy found a rectal polyp that was identified to be a carcinoid tumor using immunohistochemical staining. A macroinvasive pituitary adenoma with concomitant rectal carcinoid tumor was secreting GH, PRL, and TSH, which were believed to be in association with over-expression of Pit-1. This is the first case report of double primary tumors comprising a plurihormonal pituitary macroadenoma and rectal carcinoid tumor.

Citations

Citations to this article as recorded by  

• Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review
  Guiliang Peng, Chuanhong Guo, Yangfan Lv, Dandan Li, Ling Zhou, Rufei Shen, Yong Chen, Xin Zheng, Zheng Sun, Hongting Zheng, Min Long
  BMC Endocrine Disorders.2022;[Epub]     CrossRef

Celiac disease is an intestinal autoimmune disorder, triggered by ingestion of a gluten-containing diet in genetically susceptible individuals. The genetic predisposition is related to human leukocyte antigen (HLA) class II genes, especially HLA-DQ2-positive patients. The prevalence of celiac disease has been estimated to be ~1% in Europe and the USA, but it is rarer and/or underdiagnosed in Asia. We report a case of celiac disease in a predisposed patient, with a HLA-DQ2 heterodimer, and Graves' disease that was treated successfully with a gluten-free diet. A 47-year-old woman complained of persistent chronic diarrhea and weight loss over a 9 month period. Results of all serological tests and stool exams were negative. However, the patient was found to carry the HLA DQ2 heterodimer. Symptoms improved after a gluten-free diet was initiated. The patient has been followed and has suffered no recurrence of symptoms while on the gluten-free diet. An overall diagnosis of celiac disease was made in a genetically predisposed patient (HLA-DQ2 heterodimer) with Graves' disease.

Citations

Citations to this article as recorded by  

• Celiac Disease Genetics, Pathogenesis, and Standard Therapy for Japanese Patients
  Tasuku Tamai, Kenji Ihara
  International Journal of Molecular Sciences.2023; 24(3): 2075.     CrossRef
• Underutilization of diagnostic assays for celiac disease in Korea
  Rihwa Choi, Sang Gon Lee, Eun Hee Lee
  Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
• Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study
  Seng Chan You, Hojun Park, Dukyong Yoon, Sooyoung Park, Boyoung Joung, Rae Woong Park
  The Korean Journal of Internal Medicine.2019; 34(1): 90.     CrossRef
• Prevalence of celiac disease in Asia: A systematic review and meta-analysis
  Prashant Singh, Shubhangi Arora, Alka Singh, Tor A Strand, Govind K Makharia
  Journal of Gastroenterology and Hepatology.2016; 31(6): 1095.     CrossRef

Cushing's disease (CD) is a rare disorder characterized by the overproduction of adrenocorticotropic hormone due to a pituitary adenoma that ultimately stimulates excessive cortisol secretion from the adrenal glands. Prior to the detection of pituitary adenomas, various clinical signs of CD such as central obesity, moon face, hirsutism, and facial plethora are usually already present. Uncontrolled hypercortisolism is associated with metabolic, cardiovascular, and psychological disorders that result in increased mortality. Hence, the early detection and treatment of CD are not only important but mandatory. Because its clinical manifestations vary from patient to patient and are common in other obesity-related conditions, the precise diagnosis of CD can be problematic. Thus, the present set of guidelines was compiled by Korean experts in this field to assist clinicians with the screening, diagnoses, and treatment of patients with CD using currently available tests and treatment modalities.

Citations

Citations to this article as recorded by  

• Diet quality and dietary acid load in relation to cardiovascular disease mortality: Results from Fasa PERSIAN cohort study
  Sahar Fereidouni, Najmeh Hejazi, Reza Homayounfar, Mojtaba Farjam
  Food Science & Nutrition.2023; 11(3): 1563.     CrossRef
• Dietary acid load and mortality from all causes, CVD and cancer: results from the Golestan Cohort Study
  Ehsan Hejazi, Hadi Emamat, Maryam Sharafkhah, Atoosa Saidpour, Hossein Poustchi, Sadaf Sepanlou, Masoud Sotoudeh, Sanford Dawsey, Paolo Boffetta, Christian C Abnet, Farin Kamangar, Arash Etemadi, Akram Pourshams, Akbar Fazeltabar Malekshah, Paul Berennan,
  British Journal of Nutrition.2022; 128(2): 237.     CrossRef
• Forty Years Together, New Leap Forward! The 40th Anniversary of the Korean Endocrine Society
  Jong Chul Won, Ki-Hyun Baek
  Endocrinology and Metabolism.2022; 37(6): 851.     CrossRef
• Pituitary adenomas: current principles of diagnosis and treatment
  L. I. Astafyeva, I. V. Chernov, I. V. Chekhonin, E. I. Shults, I. N. Pronin, P. L. Kalinin
  Russian journal of neurosurgery.2021; 22(4): 94.     CrossRef
• Metabolic changes in serum steroids for diagnosing and subtyping Cushing’s syndrome
  Chang Ho Ahn, Chaelin Lee, Jaeyoon Shim, Sung Hye Kong, Su-jin Kim, Yong Hwy Kim, Kyu Eun Lee, Chan Soo Shin, Jung Hee Kim, Man Ho Choi
  The Journal of Steroid Biochemistry and Molecular Biology.2021; 210: 105856.     CrossRef
• Application of different variants of endoscopic transphenoidal removal of corticotropinomas in order to increase the frequency and duration of remission
  A. Ashraf, I. V. Chernov, A. N. Shkarubo, M. A. Kutin, D. V. Fomichev, O. I. Sharipov, Yu. Yu. Trunin, D. N. Andreev, A. A. Abdilatipov, L. I. Astafieva, B. Abdali, A. B. Kurnosov, G. E. Chmutin, Kalinin P. L. Kalinin P. L.
  Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery).2021; (2): 143.     CrossRef
• Modern aspects of surgery for cushing’s disease
  A. Abdali, L.I. Astafeva, Yu.Yu. Trunin, I.V. Chernov, Yu.G. Sidneva, A.A. Abdilatipov, P.L. Kalinin
  Voprosy neirokhirurgii imeni N.N. Burdenko.2021; 85(4): 111.     CrossRef
• Pituitary microadenomas — current diagnostic and treatment methods
  L.I. Astafyeva, B.A. Kadashev, Yu.G. Sidneva, I.V. Chernov, P.L. Kalinin
  Voprosy neirokhirurgii imeni N.N. Burdenko.2020; 84(2): 110.     CrossRef
• Usefulness of prolactin measurement in inferior petrosal sinus sampling with desmopressin for Cushing’s syndrome
  Hamideh Akbari, Mohammad Ghorbani, Maryam Kabootari, Ali Zare Mehrjardi, Mohammad Reza Mohajeri Tehrani, Mojtaba Malek, Mohammad E. Khamseh
  British Journal of Neurosurgery.2020; 34(3): 253.     CrossRef
• Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas
  Jung Soo Lim, Mi-Kyung Lee, Eunhee Choi, Namki Hong, Soo Il Jee, Sun Ho Kim, Eun Jig Lee
  Endocrine.2019; 64(1): 147.     CrossRef
• Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas
  Daham Kim, Cheol Ryong Ku, Se Hee Park, Ju Hyung Moon, Eui Hyun Kim, Sun Ho Kim, Eun Jig Lee
  World Neurosurgery.2018; 115: e464.     CrossRef
• Blood Tests for the Diagnosis of Adrenal Diseases
  Seon-Ah Cha, Sung-Dae Moon
  The Korean Journal of Medicine.2018; 93(6): 532.     CrossRef
• Choosing wisely: la lista del gruppo di studio Endocrinologia e Malattie del Metabolismo della Società Italiana di Patologia Clinica e Medicina di Laboratorio
  Romolo M. Dorizzi, Anna Ferrari, Marina Vitillo, Beatrice Caruso, Claudio Cocco, Erennio Ciotoli, Federica D’Aurizio, Elisa Esposito, Germana Giannone, Giulio Ozzola, Ottavia Porzio, Emanuela Toffalori, Renato Tozzoli
  La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine.2016; 12(2): 81.     CrossRef
• Surgical management of adrenocorticotropic hormone-secreting pituitary adenomas
  Edwin S Kulubya, Daniel A Donoho, John D Carmichael, Gabriel Zada
  International Journal of Endocrine Oncology.2016; 3(1): 41.     CrossRef